Abstract
Background
The complexity of coronary artery disease (CAD) is a predictor of cardiovascular events in patients with >50 % diameter stenosis as determined by SYNTAX score. Here, we compare the Gensini score to SYNTAX in patients with CAD as well as apply the Gensini score in patients with nonobstructive CAD (NOB-CAD), defined by ≤50 % diameter stenosis, were the SYNTAX score cannot be utilized to define future risk.
Methods
The AtheroGene study enrolled 2316 patients [861/37.2 % with acute cardiovascular syndrome (ACS) and 1500/62.8 % with stable CAD (SCAD)]. Of these, 1966 had obstructive CAD (OB-CAD) with SYNTAX and Gensini scores available and 291 events with either cardiovascular mortality or non-fatal myocardial infarction were recorded. Furthermore, 350 patients had NOB-CAD with only Gensini score and 36 events. Median follow-up time was 4.9 years.
Results
In the OB-CAD cohort the SYNTAX and the Gensini score predicted outcome. Kaplan–Meier curve analysis with the dichotomized Gensini score showed a significant result (p = 0.04) in the NOB-CAD cohort. Cox Regression analysis after adjustment showed a hazard ratio (HR) of 1.33 and p = 0.04 for the Gensini score in the NOB-CAD cohort. Receiver operating characteristic curve (ROC) analysis provided the highest area under the curve (AUC) regarding the outcome for the Gensini score with 0.65 (p = 0.004). Comparing the SYNTAX and Gensini score in this cohort showed improved discrimination of patients with events by the Gensini score (p = 0.02).
Conclusion
The Gensini score predicted events in patients with ≤50 % diameter lesions. Utilization of this score is useful to define risk in NOB-CAD patients.
Similar content being viewed by others
References
Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A (2014) 2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35(37):2541–2619. doi:10.1093/eurheartj/ehu278
Maddox TM, Stanislawski MA, Grunwald GK, Bradley SM, Ho PM, Tsai TT, Patel MR, Sandhu A, Valle J, Magid DJ, Leon B, Bhatt DL, Fihn SD, Rumsfeld JS (2014) Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA 312(17):1754–1763. doi:10.1001/jama.2014.14681
Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV, Brindis RG, Douglas PS (2010) Low diagnostic yield of elective coronary angiography. N Engl J Med 362(10):886–895. doi:10.1056/NEJMoa0907272
Franzone A, Heg D, Raber L, Valgimigli M, Piccolo R, Zanchin T, Yamaji K, Stortecky S, Blochlinger S, Hunziker L, Praz F, Juni P, Windecker S, Pilgrim T (2016) External validity of the “all-comers” design: insights from the BIOSCIENCE trial. Clin Res Cardiol. doi:10.1007/s00392-016-0983-z
Da Costa A, Isaaz K, Faure E, Mourot S, Cerisier A, Lamaud M (2001) Clinical characteristics, aetiological factors and long-term prognosis of myocardial infarction with an absolutely normal coronary angiogram; a 3-year follow-up study of 91 patients. Eur Heart J 22(16):1459–1465. doi:10.1053/euhj.2000.2553
Planer D, Mehran R, Ohman EM, White HD, Newman JD, Xu K, Stone GW (2014) Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circ Cardiovasc Interv 7(3):285–293. doi:10.1161/CIRCINTERVENTIONS.113.000606
Park DW, Kim YH, Yun SC, Song HG, Ahn JM, Oh JH, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ (2011) Complexity of atherosclerotic coronary artery disease and long-term outcomes in patients with unprotected left main disease treated with drug-eluting stents or coronary artery bypass grafting. J Am Coll Cardiol 57(21):2152–2159. doi:10.1016/j.jacc.2011.01.033
Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R, Dangas G, Lazar D, Sanchez R, Fahy M, Xu K, Stone GW (2011) Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) Trial. J Am Coll Cardiol 57(24):2389–2397. doi:10.1016/j.jacc.2011.02.032
Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1(2):219–227
Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360(10):961–972. doi:10.1056/NEJMoa0804626
Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51(3):606
Zengin E, Bickel C, Schnabel RB, Zeller T, Lackner KJ, Rupprecht HJ, Blankenberg S, Westermann D, Sinning C (2015) Risk factors of coronary artery disease in secondary prevention-results from the AtheroGene–study. PLoS One 10(7):e0131434. doi:10.1371/journal.pone.0131434
Sesso HD, Lee IM, Gaziano JM, Rexrode KM, Glynn RJ, Buring JE (2001) Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation 104(4):393–398
Gensini GG (1975) Coronary Arteriography. Futura Press, New York
Sinning C, Lillpopp L, Appelbaum S, Ojeda F, Zeller T, Schnabel R, Lubos E, Jagodzinski A, Keller T, Munzel T, Bickel C, Blankenberg S (2013) Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application. Clin Res Cardiol 102(7):495–503. doi:10.1007/s00392-013-0555-4
Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56(2):337–344
Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148(3):839–843. doi:10.1148/radiology.148.3.6878708
Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, Van Dyck N, Mack M, Holmes D, Feldman T, Morice MC, Colombo A, Bass E, Leadley K, Dawkins KD, van Es GA, Morel MA, Mohr FW (2009) Assessment of the SYNTAX score in the Syntax study. EuroIntervention 5(1):50–56
Sinning JM, Stoffel V, Grube E, Nickenig G, Werner N (2012) Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting. Clin Res Cardiol. doi:10.1007/s00392-012-0417-5
Farooq V, Vergouwe Y, Raber L, Vranckx P, Garcia-Garcia H, Diletti R, Kappetein AP, Morel MA, de Vries T, Swart M, Valgimigli M, Dawkins KD, Windecker S, Steyerberg EW, Serruys PW (2012) Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score. Eur Heart J 33(24):3098–3104. doi:10.1093/eurheartj/ehs295
Girasis C, Garg S, Raber L, Sarno G, Morel MA, Garcia-Garcia HM, Luscher TF, Serruys PW, Windecker S (2011) SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. Eur Heart J 32(24):3115–3127. doi:10.1093/eurheartj/ehr369
Sinning JM, Asdonk T, Erlhofer C, Vasa-Nicotera M, Grube E, Nickenig G, Werner N (2013) Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in elderly patients undergoing multivessel PCI. Clin Res Cardiol 102(12):865–873. doi:10.1007/s00392-013-0599-5
Arbel Y, Zlotnik M, Halkin A, Havakuk O, Berliner S, Herz I, Rabinovich I, Keren G, Bazan S, Finkelstein A, Banai S (2014) Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography. Clin Res Cardiol 103(3):223–227. doi:10.1007/s00392-013-0641-7
Johnston N, Jonelid B, Christersson C, Kero T, Renlund H, Schenck-Gustafsson K, Lagerqvist B (2015) Effect of gender on patients with ST-elevation and Non-ST-elevation myocardial infarction without obstructive coronary artery disease. Am J Cardiol 115(12):1661–1666. doi:10.1016/j.amjcard.2015.03.006
Leipsic J, Taylor CM, Gransar H, Shaw LJ, Ahmadi A, Thompson A, Humphries K, Berman DS, Hausleiter J, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Chow BJ, Cury RC, Delago AJ, Dunning AL, Feuchtner GM, Hadamitzky M, Kaufmann PA, Lin FY, Chinnaiyan KM, Maffei E, Raff GL, Villines TC, Gomez MJ, Min JK (2014) Sex-based prognostic implications of nonobstructive coronary artery disease: results from the international multicenter CONFIRM study. Radiology 273(2):393–400. doi:10.1148/radiol.14140269
Rossini R, Capodanno D, Lettieri C, Musumeci G, Limbruno U, Molfese M, Spatari V, Calabria P, Romano M, Tarantini G, Gavazzi A, Angiolillo DJ (2013) Long-term outcomes of patients with acute coronary syndrome and nonobstructive coronary artery disease. Am J Cardiol 112(2):150–155. doi:10.1016/j.amjcard.2013.03.006
Glaser R, Selzer F, Faxon DP, Laskey WK, Cohen HA, Slater J, Detre KM, Wilensky RL (2005) Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation 111(2):143–149. doi:10.1161/01.CIR.0000150335.01285.12
Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, Borrico S, Gorlin R, Fuster V (1988) Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 12(1):56–62
Reardon MF, Nestel PJ, Craig IH, Harper RW (1985) Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 71(5):881–888
Leaman DM, Brower RW, Meester GT, Serruys P, van den Brand M (1981) Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation 63(2):285–299
Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, Virmani R (1996) Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 93(7):1354–1363
Lin FY, Shaw LJ, Dunning AM, Labounty TM, Choi JH, Weinsaft JW, Koduru S, Gomez MJ, Delago AJ, Callister TQ, Berman DS, Min JK (2011) Mortality risk in symptomatic patients with nonobstructive coronary artery disease: a prospective 2-center study of 2583 patients undergoing 64-detector row coronary computed tomographic angiography. J Am Coll Cardiol 58(5):510–519. doi:10.1016/j.jacc.2010.11.078
Kristensen TS, Kofoed KF, Kuhl JT, Nielsen WB, Nielsen MB, Kelbaek H (2011) Prognostic implications of nonobstructive coronary plaques in patients with non-ST-segment elevation myocardial infarction: a multidetector computed tomography study. J Am Coll Cardiol 58(5):502–509. doi:10.1016/j.jacc.2011.01.058
Pepine CJ, Ferdinand KC, Shaw LJ, Light-McGroary KA, Shah RU, Gulati M, Duvernoy C, Walsh MN, Bairey Merz CN (2015) Emergence of nonobstructive coronary artery disease: a woman’s problem and need for change in definition on angiography. J Am Coll Cardiol 66(17):1918–1933. doi:10.1016/j.jacc.2015.08.876
Di Mario C, Moreno PR (2016) Invasive coronary imaging: any role in primary and secondary prevention? Eur Heart J. doi:10.1093/eurheartj/ehv323
Bharadwaj AS, Vengrenyuk Y, Yoshimura T, Baber U, Hasan C, Narula J, Sharma SK, Kini AS (2016) Multimodality intravascular imaging to evaluate sex differences in plaque morphology in stable CAD. JACC Cardiovasc Imaging. doi:10.1016/j.jcmg.2016.02.007
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
All authors declare no conflicts of interest.
Funding
The AtheroGene study is supported by a Grant of the ‘Stiftung Rheinland-Pfalz für Innovation’, Ministry of Science and Education (AZ 15202–386261/545), Mainz, by the MAIFOR Grant 2001 of the Johannes Gutenberg-University Mainz, Germany, and by Grants from the Fondation de France (No. 2002004994), the French Ministry of Research (ACI IMPBIO 032619) and the Institut National de la Santé et de la Recherche Médicale (Programme National de Recherches sur les Maladies Cardiovasculaires A04052DS).
Additional information
C. Sinning and E. Zengin both authors contributed equally.
P. M. Clemmensen and D. Westermann both authors were equally senior authors of this study.
Rights and permissions
About this article
Cite this article
Sinning, C., Zengin, E., Waldeyer, C. et al. SYNTAX score-0 patients: risk stratification in nonobstructive coronary artery disease. Clin Res Cardiol 105, 901–911 (2016). https://doi.org/10.1007/s00392-016-0998-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-016-0998-5